Literature DB >> 19921119

The diagnostic value of multislice computed tomography postprocessing images in coronary artery stenosis.

Ziqiao Lei1, Ping Han, Haibo Xu, Heshui Shi.   

Abstract

OBJECTIVE: To investigate the clinical application value of various multislice computed tomography (MSCT) postprocessing images in moderate coronary artery stenosis (defined as >50% stenosis).
METHODS: Sixty patients with high risk factors, whether they had suspected or confirmed coronary heart disease, underwent MSCT coronary angiography before undergoing selective coronary angiography (CAG).The transverse images obtained from the MSCT scan were compared, as well as various post-processing images (eg, multiplanar reformation [MPR], maximum-intensity projection [MIP], volume rendering technique [VRT], as well as virtual endoscopy [VE]), with CAG to evaluate the clinical significance of various MSCT postprocessing images in moderate coronary artery stenosis
RESULTS: Among the various MSCT postprocessing images, MPR had the highest sensitivity, specificity, positive predictive value, and negative predictive value in the diagnosis of moderate coronary artery stenosis, followed by VRT, VE, and with MIP having the lowest
CONCLUSION: In the diagnosis of moderate coronary artery stenosis, a comprehensive evaluation should be made by associating axial images, using MPR mainly with VRT, and using VE and MIP as supplements in order to increase the accuracy of diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19921119     DOI: 10.1007/s12325-009-0071-0

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  1 in total

1.  Diagnostic Value of Multidetector CT and Its Multiplanar Reformation, Volume Rendering and Virtual Bronchoscopy Postprocessing Techniques for Primary Trachea and Main Bronchus Tumors.

Authors:  Mingyue Luo; Chaijie Duan; Jianping Qiu; Wenru Li; Dongyun Zhu; Wenli Cai
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.